Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Introducing wicked issues for HIV pre-exposure prophylaxis implementation in the U.S.

Smith DK, Dearing JW, Sanchez T, Goldschmidt RH.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S59-62. doi: 10.1016/j.amepre.2012.09.057. No abstract available.

PMID:
23253763
2.

A proposed framework to monitor daily oral antiretroviral pre-exposure prophylaxis in the U.S.

Smith DK, Beltrami J.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S141-6. doi: 10.1016/j.amepre.2012.09.040. Review. No abstract available.

PMID:
23253756
3.

Next steps in designing for diffusion of pre-exposure prophylaxis: demonstration projects.

Dearing JW, Norton WE, Larson RS.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S156-60. doi: 10.1016/j.amepre.2012.09.028. Review. No abstract available.

PMID:
23253759
4.

Providing HIV pre-exposure prophylaxis: lessons learned from the Ryan White HIV/AIDS Program.

Trent-Adams S, Cheever LW.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S147-50. doi: 10.1016/j.amepre.2012.09.031. Review. No abstract available.

PMID:
23253757
5.

Financial policy issues for HIV pre-exposure prophylaxis: cost and access to insurance.

Horberg M, Raymond B.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S125-8. doi: 10.1016/j.amepre.2012.09.039. Review. No abstract available.

PMID:
23253752
6.

Primary care and public health partnerships for implementing pre-exposure prophylaxis.

Norton WE, Larson RS, Dearing JW.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S77-9. doi: 10.1016/j.amepre.2012.09.037. Review. No abstract available.

PMID:
23253766
7.

Social justice, public health ethics, and the use of HIV pre-exposure prophylaxis.

Philpott S.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S137-40. doi: 10.1016/j.amepre.2012.09.029. Review. No abstract available.

PMID:
23253755
8.

Antiretroviral prophylaxis for sexual and injection drug use acquisition of HIV.

Campbell JD, Herbst JH, Koppenhaver RT, Smith DK.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S63-9. doi: 10.1016/j.amepre.2012.09.045. Review.

PMID:
23253764
9.

HIV pre-exposure prophylaxis diffusion and implementation issues in nonclinical settings.

Hosek SG.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S129-32. doi: 10.1016/j.amepre.2012.09.032. Review. No abstract available.

PMID:
23253753
10.

Adherence to antiretroviral medications for HIV pre-exposure prophylaxis: lessons learned from trials and treatment studies.

Koenig LJ, Lyles C, Smith DK.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S91-8. doi: 10.1016/j.amepre.2012.09.047. Review. No abstract available.

PMID:
23253769
11.

Provider-initiated HIV-risk behavior counseling in the context of HIV pre-exposure prophylaxis.

Thrun MW.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S108-11. doi: 10.1016/j.amepre.2012.09.034. Review. No abstract available.

PMID:
23253749
12.

Brief risk-reduction counseling in clinical settings for HIV pre-exposure prophylaxis.

Malotte CK.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S112-8. doi: 10.1016/j.amepre.2012.09.033. Review. No abstract available.

PMID:
23253750
13.

Using registries to monitor HIV pre-exposure prophylaxis safety in clinical settings.

Tilson HH.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S151-5. doi: 10.1016/j.amepre.2012.09.042. Review. No abstract available.

PMID:
23253758
14.

Preparing for HIV pre-exposure prophylaxis: lessons learned from post-exposure prophylaxis.

Cohen SE, Liu AY, Bernstein KT, Philip S.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S80-5. doi: 10.1016/j.amepre.2012.09.036. Review. No abstract available.

15.

Cost-effectiveness of pre-exposure prophylaxis for HIV: a review.

Schackman BR, Eggman AA.

Curr Opin HIV AIDS. 2012 Nov;7(6):587-92. doi: 10.1097/COH.0b013e3283582c8b. Review.

PMID:
23076124
16.

State adolescent consent laws and implications for HIV pre-exposure prophylaxis.

Culp L, Caucci L.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S119-24. doi: 10.1016/j.amepre.2012.09.044. Review.

PMID:
23253751
17.

Disseminating HIV pre-exposure prophylaxis information in underserved communities.

Dutta MJ.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S133-6. doi: 10.1016/j.amepre.2012.09.030. Review. No abstract available.

PMID:
23253754
18.

Applying chronic illness care, implementation science, and self-management support to HIV.

Elzarrad MK, Eckstein ET, Glasgow RE.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S99-107. doi: 10.1016/j.amepre.2012.09.046. Review. No abstract available.

PMID:
23253770
19.

Moving HIV pre-exposure prophylaxis into clinical settings: lessons from buprenorphine.

Edelman EJ, Fiellin DA.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S86-90. doi: 10.1016/j.amepre.2012.09.035. Review. No abstract available.

20.

HIV post-exposure prophylaxis: complex issues in health care worker management.

Ball RT Jr.

J S C Med Assoc. 1996 Oct;92(10):437-40. Review. No abstract available.

PMID:
8990671

Supplemental Content

Support Center